Reaction
Hilar Lymphadenopathy reporting signals
As of the last recalculation, Hilar Lymphadenopathy appears in 861 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is CHLORHEXIDINE GLUCONATE (PRR 29.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Chlorhexidine Gluconate | 11 | 29.5 | 29.5 |
| Pyrazinamide | 11 | 28.7 | 28.7 |
| Fulvestrant | 35 | 26.7 | 26.7 |
| Exemestane | 22 | 25.5 | 25.5 |
| Moxifloxacin Hydrochloride | 20 | 24.4 | 24.4 |
| Polatuzumab Vedotin | 9 | 22.5 | 22.5 |
| Efavirenz | 10 | 21.9 | 21.9 |
| Goserelin | 12 | 21.9 | 21.9 |
| Azithromycin | 34 | 21.2 | 21.2 |
| Isoniazid | 14 | 21.2 | 21.2 |
| Azithromycin Monohydrate | 34 | 20.5 | 20.5 |
| Busulfan | 12 | 18.7 | 18.7 |
| Ciprofloxacin Hydrochloride And Hydrocortisone | 15 | 17.7 | 17.7 |
| Dabrafenib | 15 | 17.5 | 17.5 |
| Letrozole | 42 | 17.3 | 17.3 |
| Letrozole Tablets | 33 | 17.2 | 17.2 |
| Alpelisib | 6 | 16.7 | 16.8 |
| Etonogestrel And Ethinyl Estradiol | 14 | 15.5 | 15.5 |
| Trametinib | 15 | 15.3 | 15.3 |
| Fluticasone Furoate And Vilanterol Trifenatate | 22 | 15.1 | 15.2 |
| Rifampin | 9 | 15.1 | 15.1 |
| Rifampicin | 6 | 14.4 | 14.4 |
| Bendamustine Hcl | 9 | 14.2 | 14.2 |
| Tenofovir Disoproxil Fumarate Tablets | 5 | 14.1 | 14.1 |
| Tiotropium Bromide Inhalation Spray | 5 | 10.8 | 10.8 |
| Gefitinib | 4 | 10.8 | 10.8 |
| Durvalumab | 8 | 9.6 | 9.6 |
| Pemetrexed | 8 | 9.1 | 9.1 |